Myriad Genetics
MYGN
MYGN
197 hedge funds and large institutions have $2.16B invested in Myriad Genetics in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 76 increasing their positions, 63 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $2.55B → $2.16B (-$395M)
35% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 37
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
197
Holding in Top 10
–
Calls
$11M
Puts
$2.77M
Top Buyers
| 1 | +$31M | |
| 2 | +$30.2M | |
| 3 | +$15.8M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$13.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.21M |
Top Sellers
| 1 | -$23.4M | |
| 2 | -$19.1M | |
| 3 | -$18.9M | |
| 4 |
GCM
Glenview Capital Management
New York
|
-$15.3M |
| 5 |
Morgan Stanley
New York
|
-$11.2M |